Literature DB >> 35567607

Genotype-Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism.

Anima Sharma1, Saba Memon1, Anurag R Lila1, Vijaya Sarathi2, Sneha Arya1, Swati S Jadhav3, Priya Hira4, Mahadeo Garale5, Vikrant Gosavi1, Manjiri Karlekar1, Virendra Patil1, Tushar Bandgar6.   

Abstract

Childhood and adolescent primary hyperparathyroidism (PHPT) is a very rare disease. Data on its molecular genetics are scarce. We performed a retrospective analysis (January 2000-January 2021) to determine the deleterious germline variants and genotype-phenotype correlations in children and adolescents < 20 years diagnosed with PHPT from a single referral center. Clinical features, biochemistry, imaging, management, and genetics (clinical exome analyzed for 11 PHPT and 7 pancreatitis-associated genes, MLPA for CDC73) were recorded. Thirty-six patients (20 males; median age 17 years) were classified into those with familial and/or syndromic (F/S) or apparently sporadic (AS) presentation. Sixteen (44.4%) harbored pathogenic/likely pathogenic germline variants in PHPT-associated genes. The genetic yield in F/S group was 90% (MEN1:8/10; CDC73:1/10), and AS group was 26.9% (CDC73:4/26; CASR:3/26). F/S group had frequent asymptomatic presentation (60% vs none; P < 0.001), lower serum PTH (237.5 vs 1369.1 pg/mL; P = 0.001), and maximum parathyroid dimension (0.9 vs 2.2 cm; P = 0.01) than AS group. Among the AS group, renal involvement was higher in those with molecular diagnoses (71.4% vs 10.5%; P = 0.01). All those with novel CASR variants (including one homozygous) had hypercalciuria and histology-proven parathyroid adenoma/carcinoma. A missense CTRC VUS occurred in one patient with chronic pancreatitis. In summary, Asian Indian children and adolescents with PHPT have high genetic yield, even with apparently sporadic presentation. The phenotypic spectrum of CASR variants is expanded to include childhood/adolescent PHPT with hypercalciuria and single gland neoplasia. The proposed roles for renal involvement to predict molecular diagnosis among those with apparently sporadic presentation require further elucidation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CASR; CDC73; Childhood and adolescent primary hyperparathyroidism; Genetics of pancreatitis; Genotype–phenotype correlation; MEN1

Mesh:

Substances:

Year:  2022        PMID: 35567607     DOI: 10.1007/s00223-022-00985-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.000


  31 in total

1.  New Concepts About Familial Isolated Hyperparathyroidism.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2019-03-08       Impact factor: 5.958

2.  MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.

Authors:  Letizia Vannucci; Francesca Marini; Francesca Giusti; Simone Ciuffi; Francesco Tonelli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2017-05-22       Impact factor: 3.633

3.  Aetiology, Diagnosis and Surgical Treatment of Primary Hyperparathyroidism in Children: New Trends.

Authors:  Swethan Alagaratnam; Tom R Kurzawinski
Journal:  Horm Res Paediatr       Date:  2015-05-01       Impact factor: 2.852

4.  CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.

Authors:  Karin van der Tuin; Carli M J Tops; Muriel A Adank; Jan-Maarten Cobben; Neveen A T Hamdy; Marjolijn C Jongmans; Fred H Menko; Bernadette P M van Nesselrooij; Romana T Netea-Maier; Jan C Oosterwijk; Gerlof D Valk; Bruce H R Wolffenbuttel; Frederik J Hes; Hans Morreau
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

5.  MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.

Authors:  P Goudet; A Dalac; M Le Bras; C Cardot-Bauters; P Niccoli; N Lévy-Bohbot; H du Boullay; X Bertagna; P Ruszniewski; F Borson-Chazot; B Vergès; J L Sadoul; F Ménégaux; A Tabarin; J M Kühn; P d'Anella; O Chabre; S Christin-Maitre; G Cadiot; C Binquet; B Delemer
Journal:  J Clin Endocrinol Metab       Date:  2015-01-16       Impact factor: 5.958

6.  Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.

Authors:  Vito Guarnieri; Lucie Canaff; Francisco H J Yun; Alfredo Scillitani; Claudia Battista; Lucia A Muscarella; Betty Y L Wong; Angelantonio Notarangelo; Leonardo D'Agruma; Michele Sacco; David E C Cole; Geoffrey N Hendy
Journal:  J Clin Endocrinol Metab       Date:  2010-02-17       Impact factor: 5.958

7.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

8.  The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Robert Udelsman; Göran Åkerström; Carlo Biagini; Quan-Yang Duh; Paolo Miccoli; Bruno Niederle; Francesco Tonelli
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

9.  Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population.

Authors:  Yasmine El Allali; Coralie Hermetet; Justine Bacchetta; Cyril Amouroux; Anya Rothenbuhler; Valérie Porquet-Bordes; Marie-Alexandrine Champigny; Sabine Baron; Pascal Barat; Hélène Bony-Trifunovic; Karine Bourdet; Kanetee Busiah; Maryse Cartigny-Maciejewski; Florence Compain; Régis Coutant; Jessica Amsellem-Jager; Marc De Kerdanet; Nathalie Magontier; Brigitte Mignot; Odile Richard; Sylvie Rossignol; Sylvie Soskin; Aurélie Berot; Catherine Naud-Saudreau; Jean-Pierre Salles; Agnès Linglart; Thomas Edouard; Anne Lienhardt-Roussie
Journal:  Eur J Endocrinol       Date:  2021-02       Impact factor: 6.664

Review 10.  Multiple Endocrine Neoplasia Type 1: Latest Insights.

Authors:  Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.